Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England

Clinical trial NCT03278067 · COMPLETED

Trial details

NCT number: NCT03278067
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Influenza, Human

Start date: 2017-09-12
Primary completion: 2017-11-30
Enrollment: 23939

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.